Aster DM Healthcare Limited — Investor Meet, 09-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Aster DM Healthcare's Q3 FY26 earnings call highlighted strong combined proforma performance with revenue up 15% YoY to INR 2,366 Cr and Operating EBITDA up 22% YoY to INR 503 Cr (21% margin). Aster standalone revenue grew 13% YoY, while QCIL revenue grew 17.3% YoY with margin expansion. The proposed merger with Quality Care India is progressing, with NCLT approval anticipated in Q1 FY27. Management aims for a 24-25% EBITDA margin for the combined entity in 2-3 years, driven by disciplined capacity expansion, clinical talent, and procurement synergies. Kasargod hospital is expected to break even next quarter. The management expresses confidence in sustained growth and margin improvement.